Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Diagnostics Omics, Precision medicine, Genetics and epigenetics, Oncology

A Tipping Point for Comprehensive Genomic Profiling in Cancer

Precision medicine offers valuable information not just for diagnosis and treatment selection, but also for patient stratification and prognosis. But powerful tools need powerful methods – which is why comprehensive genomic profiling may be the way forward for precision oncology.

Oncology has reached a tipping point and its name is “precision medicine.” No doubt you will have heard of it; in fact, it may well form a substantial part of your daily work. Over the last few years, we have seen tremendous advances in research and in the clinic, thanks, at least in part, to the adoption of comprehensive genomic profiling (CGP), which helps guide treatment decisions based on the molecular drivers of disease. Precision medicine is changing the outlook for many people living with cancer – especially those facing advanced disease.

In breast cancer specifically, we’ve seen an avalanche of research and subsequent progress that spans multiple decades and shapes modern oncology. The progress we’re making for breast cancer patients every day is exciting and provides a glimpse into the potential of CGP and precision medicine not just for breast cancer, but for oncology as a whole.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Cindy Perettie

Chief Executive Officer of Foundation Medicine, Cambridge, Massachusetts, USA.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register